Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.

The secret to a healthier and "younger" heart lies in the vagus nerve. A recent study coordinated by the Sant'Anna School of ...

Cytokinetics has announced that the US Food and Drug Administration (FDA) has approved MYQORZO (aficamten) tablets in 5mg, ...

Cytokinetics' heart-disease drug Myqorzo was approved by the Food and Drug Administration. The San Francisco biopharmaceutical company said Friday that Myqorzo had been approved in 5, 10, 15 and 20 ...

Cytokinetics (CYTK) announced that the U.S. Food and Drug Administration has approved Myqorzo, 5 mg, 10 mg, 15 mg, 20 mg tablets for the treatment ...

GLP-1s improved outcomes in patients with heart failure with preserved ejection fraction, with or without obesity, but those ...

Abstract: Studies of cardiovascular system have been the hot point generally concerned as well as extraordinarily significant issue of bioscience. Because of the complexity of cardiovascular system, ...

Abstract: Uterine mechanical behavior in the form of uterine contraction plays a key role in reproduction. Irregular patterns of uterine contractility associate with dysfunctions of the uterus.

Objectives Patients with rheumatoid arthritis (RA) display an increased risk of heart failure independent of traditional cardiovascular risk factors. To elucidate myocardial disease in RA, we have ...